Skip to main content
Clinical Trials/NCT05066659
NCT05066659
Unknown
N/A

Relationship Between Balance Performance and Corticomotor Inhibition in Individuals With Parkinsons' Disease

National Yang Ming Chiao Tung University1 site in 1 country50 target enrollmentOctober 8, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
National Yang Ming Chiao Tung University
Enrollment
50
Locations
1
Primary Endpoint
Functional balance
Last Updated
4 years ago

Overview

Brief Summary

Postural instability is one of the motor features of Parkinson's disease (PD). Most patients will develop balance dysfunction, and they may get worse with disease progression. According to previous studies, people with PD had abnormal changes in corticomotor excitability, especially disinhibition in the primary motor cortex (M1). Some evidence had shown that the cortical function in the M1 is crucial for the pathophysiology of the underlying motor symptoms in PD. Furthermore, neurostimulation over the M1 could modulate the corticomotor excitability in individuals with PD, and then improve their motor and also balance performance. However, whether the impaired corticomotor inhibition relates to balance dysfunction in people with PD is still unknown. In this study, the purpose is to investigate the possible relationship between corticomotor inhibition and balance performance in individuals with PD. However, the postural position during TMS measurement may affect the corticomotor excitability. To further establish the above-mentioned relationship, the secondary purpose is to explore and confirm whether the postural position will influence the correlation.

Registry
clinicaltrials.gov
Start Date
October 8, 2021
End Date
September 8, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yea-Ru Yang

Professor

National Yang Ming Chiao Tung University

Eligibility Criteria

Inclusion Criteria

  • the Hoehn and Yahr stage between 1 and 3
  • age 40 to 80 years
  • a stable treatment of anti-PD medications

Exclusion Criteria

  • any contraindications of TMS
  • any injury histories or disorders affecting balance
  • any neurosurgery experience
  • neurologic conditions other than PD
  • the Mini-mental State Examination (MMSE) score \< 24

Outcomes

Primary Outcomes

Functional balance

Time Frame: 15 minutes

Mini-Balance Evaluation Systems Test

Intracortical inhibition

Time Frame: 20 minutes

Short-interval intracortical inhibition assessed by transcranial magnetic stimulation

Corticospinal inhibition

Time Frame: 20 minutes

Cortical silent period assessed by transcranial magnetic stimulation

Static balance

Time Frame: 3 minutes

Sharpened Romberg test

Dynamic balance

Time Frame: 5 minutes

Functional reach test

Study Sites (1)

Loading locations...

Similar Trials